These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

427 related articles for article (PubMed ID: 10931319)

  • 1. Multidrug resistance mechanisms: drug efflux across two membranes.
    Zgurskaya HI; Nikaido H
    Mol Microbiol; 2000 Jul; 37(2):219-25. PubMed ID: 10931319
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Molecular analysis of efflux pump-based antibiotic resistance.
    Zgurskaya HI
    Int J Med Microbiol; 2002 Jul; 292(2):95-105. PubMed ID: 12195740
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Channel-tunnels: outer membrane components of type I secretion systems and multidrug efflux pumps of Gram-negative bacteria.
    Andersen C
    Rev Physiol Biochem Pharmacol; 2003; 147():122-65. PubMed ID: 12783268
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multiple antibiotic resistance and efflux.
    Nikaido H
    Curr Opin Microbiol; 1998 Oct; 1(5):516-23. PubMed ID: 10066525
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanism of coupling drug transport reactions located in two different membranes.
    Zgurskaya HI; Weeks JW; Ntreh AT; Nickels LM; Wolloscheck D
    Front Microbiol; 2015; 6():100. PubMed ID: 25759685
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antibiotic resistance caused by gram-negative multidrug efflux pumps.
    Nikaido H
    Clin Infect Dis; 1998 Aug; 27 Suppl 1():S32-41. PubMed ID: 9710669
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Significance of efflux pumps in multidrug resistance of Gram-negative bacteria].
    Wiercińska O; Chojecka A; Kanclerski K; Rőhm-Rodowald E; Jakimiak B
    Med Dosw Mikrobiol; 2015; 67(1):55-62. PubMed ID: 26084076
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multidrug Efflux Pumps and the Two-Faced Janus of Substrates and Inhibitors.
    Zgurskaya HI; Walker JK; Parks JM; Rybenkov VV
    Acc Chem Res; 2021 Feb; 54(4):930-939. PubMed ID: 33539084
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antibacterial efflux systems.
    Marshall NJ; Piddock LJ
    Microbiologia; 1997 Sep; 13(3):285-300. PubMed ID: 9353747
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Assembly and operation of bacterial tripartite multidrug efflux pumps.
    Du D; van Veen HW; Luisi BF
    Trends Microbiol; 2015 May; 23(5):311-9. PubMed ID: 25728476
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The role of cell wall organization and active efflux pump systems in multidrug resistance of bacteria].
    Hasdemir U
    Mikrobiyol Bul; 2007 Apr; 41(2):309-27. PubMed ID: 17682720
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Outer membranes and efflux: the path to multidrug resistance in Gram-negative bacteria.
    Poole K
    Curr Pharm Biotechnol; 2002 Jun; 3(2):77-98. PubMed ID: 12022261
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular architecture of the bacterial tripartite multidrug efflux pump focusing on the adaptor bridging model.
    Song S; Kim JS; Lee K; Ha NC
    J Microbiol; 2015 Jun; 53(6):355-64. PubMed ID: 26025167
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Multiantibiotic resistance caused by active drug extrusion in Pseudomonas aeruginosa and other gram-negative bacteria.
    Nakae T
    Microbiologia; 1997 Sep; 13(3):273-84. PubMed ID: 9353746
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mechanism of antibiotic efflux in Gram-negative bacteria.
    Zgurskaya HI; Krishnamoorthy G; Tikhonova EB; Lau SY; Stratton KL
    Front Biosci; 2003 Sep; 8():s862-73. PubMed ID: 12957812
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A model of a transmembrane drug-efflux pump from Gram-negative bacteria.
    Fernandez-Recio J; Walas F; Federici L; Venkatesh Pratap J; Bavro VN; Miguel RN; Mizuguchi K; Luisi B
    FEBS Lett; 2004 Dec; 578(1-2):5-9. PubMed ID: 15581607
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Unravelling the mechanisms of the biogenesis of the outer membrane of Gram-negative bacteria: a step toward the development of new antibiotics].
    Collet JF
    Bull Mem Acad R Med Belg; 2009; 164(7-9):213-20; discussion 220. PubMed ID: 20218188
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preventing drug access to targets: cell surface permeability barriers and active efflux in bacteria.
    Nikaido H
    Semin Cell Dev Biol; 2001 Jun; 12(3):215-23. PubMed ID: 11428914
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Mechanisms of solvent tolerance in gram-negative bacteria.
    Ramos JL; Duque E; Gallegos MT; Godoy P; Ramos-Gonzalez MI; Rojas A; Teran W; Segura A
    Annu Rev Microbiol; 2002; 56():743-68. PubMed ID: 12142492
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efflux pumps of gram-negative bacteria, a new target for new molecules.
    Pagès JM; Sandrine AF; Mahamoud A; Bolla JM; Davin-Regli A; Chevalier J; Garnotel E
    Curr Top Med Chem; 2010; 10(18):1848-57. PubMed ID: 20615189
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.